# Stephen Lyle

> Stephen Lyle is a startup investor at Stage 1 Ventures (Waltham). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Stage 1 Ventures](https://shizune.co/investors/profile/stage-1-ventures)
- Location: Waltham, United States
- Last updated: Aug 2026

Stephen Lyle is a startup investor at Stage 1 Ventures in Waltham. Dr. Lyle is the Director of KEW Group’s Molecular Diagnostics Lab and is the former Lab Director of Predictive Biosciences, and former Medical Director of Catalyst Oncology, Inc. He has served as a consultant for a number of biotech companies including Pavonis/Beauty Medicines, Switch Biotech AG, Andorra, Inc./Living Proof, Dyax Corp.,Diagnocure, Inc., Arresto Biosciences, Merrimack Pharmaceuticals and Bioserve.Dr. Lyle holds an appointment as Associate Professor of Cancer Biology and Pathology, UMass Medical School and is the Co-Director of the UMass Cancer Center Tissue Bank. He has held NIH and private foundation grants to study adult stem cell biology, cancer stem cells and skin biology. He has received a multiple awards, grants and fellowships from The National Institutes of Health, William Keck Foundation, The Ellison Foundation, Society of Investigative Dermatology, Dermatology Foundation, Burroughs Wellcome Trust, and The March of Dimes. He is a member of The American Association for Cancer Research, The Society of Investigative Dermatology and is a Fellow of the College of American Pathologists. He is an author on over 75 research publications, book chapters and reviews.Prior to his clinical fellowship training in the Harvard Combined Dermatopathology Program, he was a resident and surgical pathology fellow at the Hospital of the University of Pennsylvania, where he received the prestigious HT Enterline Fellowship Award. While at the University of Pennsylvania, he also completed a research post-doctoral fellowship in the lab of George Cotsarelis, M.D. in the Department of Dermatology. During this time Dr. Lyle made the breakthrough discovery of the location and characteristics of adult epithelial stem cells in human skin that launched his research career.Dr. Lyle is a graduate of The Pritzker School of Medicine/University of Chicago where he completed his M.D. and Ph.D. in Biochemistry and Molecular Biology. He also graduated with honors from the University of Chicago in the combined B.A. / M.S. program in Biochemistry

## About Stage 1 Ventures

VC Fund · Waltham, United States

Stage 1 Ventures is an early stage venture capital firm that is seeking to build partnerships with great entrepreneurs that are flexible and who want to build meaningful companies. They want to assist you with their global network of relationships as well as provide the capital you need to fuel the growth of your company.Their market focus todayis in Mobile, the Executable Internet or Software as a Service (SaaS) , IPTV and Internet Video, Pay-For-Performance Marketing and Advertising, and Security.

5 contacts available at Stage 1 Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Bill O’Connell | Operating Partner | https://shizune.co/investors/profile/bill-oconnell-2 |
| David H Buckley | Operating Partner | https://shizune.co/investors/profile/david-h-buckley |
| David William Baum | Founder, Partner & Managing Director | https://shizune.co/investors/profile/david-william-baum |
| Joesph Pianelli | Operating Partner | https://shizune.co/investors/profile/joesph-pianelli |
| Stephen Lyle | Operating Partner | https://shizune.co/investors/profile/stephen-lyle |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co